glp 1 rash on face Ozempic® Face: What is it and how can you avoid it Rash - Reaction from Oxempic?

Compounding pharmacies operate under regulatory oversight from state pharmacy boards, the FDA for active pharmaceutical ingredient sourcing, the DEA, and USP standards - but a compounded medication occupies a materially different regulatory category than an FDA-approved finished drug product

Freitas S, Merkle HP, Gander B

Cold temperatures slam the brakes on these molecular interactions, preserving the peptides integrity for the long haul

Understanding your dosing schedule is the first step toward optimizing results with personalized GLP-1 therapy

The long-term safety and sustained efficacy of PT-141 was demonstrated in the 52-week open-label extension of the RECONNECT trials

The international Consensus Statement discusses the options in detail and emphasises that management needs to be individualised (Buzzetti et al, 2020)